Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.5B | 3.0B | 3.2B | 2.8B |
Cost of revenue | 2.0B | 2.3B | 2.3B | 2.1B |
Gross profit | 534.2M | 764.2M | 896.5M | 675.7M |
Operating expense | ||||
Research & development | 371.8M | 405.3M | 389.1M | 330.4M |
Selling general and admin | 276.0M | -564.4M | 706.1M | -147.6M |
Other operating expenses | 21.6M | 25.2M | 23.7M | 19.9M |
Operating income | -93.9M | 90.3M | 238.8M | 87.2M |
Non operating interest income | ||||
Income | 14.0M | 25.7M | 25.7M | 11.4M |
Expense | 48.5M | 53.8M | 51.2M | 51.3M |
Other income expense | — | — | — | — |
Pretax income | -157.3M | 103.8M | 88.6M | 12.9M |
Tax provision | -100.7M | -26.0M | -45.8M | -46.7M |
Net income | -56.5M | 129.8M | 134.4M | 59.6M |
Basic EPS | 0.0 | — | — | — |
Diluted EPS | 0.0 | — | — | — |
Basic average shares | 1.2B | — | — | — |
Diluted average shares | 1.2B | — | — | — |
EBITDA | -61.7M | 241.5M | 208.4M | 123.3M |
Net income from continuing op. | — | — | — | — |
Minority interests | 32.8M | 32.5M | 31.8M | 32.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |